Highlights Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
3,779 ^JPY	+1.86%		+1.61%	-12.34%

Apr. 11	Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	MT
Jan. 12	Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	Apr. 11	MT
Final dividend	Feb. 27	FA
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	Jan. 12	MT
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024	Jan. 11	CI
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024	Jan. 11	CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	Dec. 26	CI
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.	Dec. 24	CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	Dec. 05	CI
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales	23-10-08	MT
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023	23-10-06	CI
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	23-09-04	CI
Ex-dividend day for interim dividend	23-08-29	FA
Hisamitsu Pharmaceutical Attributable Profit More Than Doubles in Fiscal Q1; Shares Climb 11%	23-07-13	MT
Hisamitsu Pharmaceutical Co., Inc. announces an Equity Buyback for 2,000,000 shares, for ¥10,000 million.	23-07-13	CI
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024	23-07-13	CI
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024	23-07-13	CI
Hisamitsu Pharmaceutical Co., Inc. authorizes a Buyback Plan.	23-07-12	CI
Hisamitsu Pharmaceutical Affirms Final Dividend on Higher FY23 Profit, Revenue	23-04-14	MT
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Year 2023, Effective May 26, 2023	23-04-13	CI
Hisamitsu Pharmaceutical Co., Inc. Provides Dividend Guidance for the Second Quarter of Fiscal 2024 and Full Year Ending February 29, 2024	23-04-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hisamitsu Pharmaceutical Co., Inc.

Equities

4530

JP3784600003

Highlights

Filters